JPMorgan Downgrades Century Therapeutics (IPSC) to Neutral 'in view of Lengthy Timelines to Meaningful POC for Lead CNTY-101'

August 28, 2023 2:08 AM EDT Send to a Friend
(Updated - August 28, 2023 4:33 AM EDT)

JPMorgan analyst Eric Joseph downgraded Century Therapeutics (NASDAQ: IPSC) from Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login